时隔17年,这篇一区SCI因图片重复问题终于被撤稿了

现在技术越来越先进,特别是对于鉴别图片重复问题,例如这篇2004年发表的一区SCI就是因为图片重复使用问题于2021年3月5日被撤稿了,文章发表在British Journal of Cancer上,该期刊属于nature子刊,也是专业内的老牌期刊。这篇文章多张图片涉嫌与别的文章重复,由于作者没有办法提供原始数据证明就期刊编辑部撤稿了。

文章题目:Retraction Note to: Id-1 stimulates cell proliferation through activation of EGFR in ovarian cancer cells

官方撤稿理由如下:

The Editor-in-Chief has retracted this article because serious concerns have been raised about integrity of the data. Specifically:

Figure 1a—the Id-1 and Actin bands for the Skov3 panel appear to be very similar.

The Actin bands in the Ovca433 panel in Figure 1a seem very similar to the Actin bands for the Ovca433 panel in Figure 4a.

Figure 1a—it appears that some images have been published earlier with different labels by some of the same authors.

In Figure 1b the Actin band for the Ovca420 panel and the Actin band for the Ovca432 panel seem to be mirror images[1,2].

The authors were unable to provide raw data. The data reported in this article are therefore unreliable.

S.W. Tsao agrees to this retraction. The editor was not able to obtain a current email address for X. Zhang, M.-T. Ling, H. Feng, Y.C. Wong and X. Wang.

参考文章:

1、Ling, M., Wang, X. S., Ouyang, X., Xu, K., Tsao, S. W. & Wong, Y. C. Id-1 expression promotes cell survival through activation of NF-kB signalling pathway in prostate cancer cells. Oncogene 22, 4498–4508, https://doi.org/10.1038/sj.onc.1206693 (2003).

2、Cheung, H. W., Ling, M.-t, Tsao, S. W., Wong, Y. C. & Wang, X. Id-1-induced Raf/MEK pathway activation is essential for its protective role against taxol-induced apoptosis in nasopharyngeal carcinoma cells. Carcinogenesis 25, 881–887, https://doi.org/10.1093/carcin/bgh087 (2004).

图片重复使用细节问题:

撤稿官网:https://www.nature.com/articles/s41416-021-01322-z#author-information

参考链接:https://pubpeer.com/publications/3C214F7C44E6D22BD9F8FA367BD232

(0)

相关推荐

  • 开源sci期刊审稿快吗

    开源sci期刊审稿快吗

  • SCI文章的重复率,多少是安全的?

    对于科研学者来说,在写SCI文章时,为提高写作效率,有意无意地从他人或者自己的文章中参考一些语句,这种是十分常见的,但也会导致文章的重复率较高.明明是自己的科研成果,若因查重不通过而被杂志定拒收,那可 ...

  • 发表SCI期刊,对作者人群有没有要求

    发表SCI期刊,对作者人群有没有要求

  • 如何知道哪个SCI期刊在征稿

    如何知道哪个SCI期刊在征稿

  • sci期刊投稿为什么难

    sci期刊投稿为什么难

  • 宠粉时间到!快来看看这个Q1区SCI期刊是不是你提的

    本期直播主题:如何零基础从头开始一项医学研究课题 点击预约按钮,领开播好礼! 解螺旋公众号·陪伴你科研的第2684天 看看那个幸运儿 之前有小伙伴在留言区说想要了解一下Stem Cells期刊,今天是 ...

  • sci自引率高会怎样

    sci自引率高会怎样?sci自引率不是越低越好,也不是越高越好,它有一个常规的合理值,在合理值前,sci自引率越高,越受作者欢迎,而在合理值后,sci自引率越高,被剔除sci的风险就会越高. 一本sc ...

  • sci论文是审稿前查重吗

    新年愿望! Happy New Year 明年继续努力工作攒钱钱 SCI论文是审稿前查重吗?是的.查重过后若是重复率过高,杂志社可能就会直接拒稿,若是与所要求的重复率相差不是很多,则会操作退修,让作者 ...

  • SCI一稿多投能不能被查到

    发表SCI论文,有比较高的拒稿率,很多作者就想多投一期刊可能命中率高点.但又怕自己的一稿多投被查到给自己带来严重的后果.那么,SCI一稿多投能被查到吗?当然能. SCI一稿多投是每本SCI期刊都明确提 ...

  • SCI期刊推荐 | 只要和干细胞相关的都可以投稿的期刊

    小主,点击上方蓝字关注我吧 小燕子 中科启帆医学编译是医学领域高端科研服务平台,专注于SCI量身定做,实验数据真实有效,提供论文修改.翻译.润色.评估.编译等服务. 如果您有对我们感兴趣,小燕子随时欢 ...